{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:56:36Z","timestamp":1792626996226,"version":"4.5.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Gouty arthritis is a metabolic condition caused by disordered purine metabolism and elevated uric acid levels. This study adopts a bibliometric approach to analyze current research on pain in gouty arthritis and forecast future research trends.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrieve relevant research on gouty arthritis pain in the Web of Science core collection database, screen literature, and use visualization software such as CiteSpace, Vosviewers, and R package \u201cBibliometrix\u201d for analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The total number of documents included was 1133, with 909 articles and 224 reviews. Between 2014 and 2024, there was an overall upward trend in the number of publications about pain in gouty arthritis, with the United States of America and China ranking first and second, respectively, in terms of publication volume. The UNIVERSITY OF ALABAMA BIRMINGHAM had the most publications, and Professor DALBETH N played a key role in this field. According to the keyword analysis, disease management and treatment, particularly methods for enhancing patients\u2019 quality of life and reducing symptoms, are research hotspots. For a deeper understanding, attention is also being paid to the epidemiology and pathological mechanisms of the disease. Emerging keywords such as \u201cgut microbiota\u201d and \u201curate-lowering therapies\u201d indicate growing interest in the interrelationship between gut microbiota and gout, and the development of new treatment methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This bibliometric study reveals that research on gouty arthritis pain is actively developing. Current hot topics reflect investigations into the deeper pathological mechanisms of gouty arthritis and the development of new treatment methods, including urate-lowering therapies. There is also increasing attention on the role of gut microbiota in the disease. Despite limitations such as the preliminary nature of research methods and insufficient interdisciplinary collaboration, future research directions aim to improve the rigor of research design, strengthen international cooperation, promote unified treatment guidelines, and optimize the diagnosis and treatment of gouty arthritis with new technologies like artificial intelligence, precision medicine, and nanomedicine. This will drive the field towards a deeper scientific understanding, more effective treatment methods, and more comprehensive disease management, ultimately improving patients\u2019 prognosis and quality of life.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040525","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:55:14Z","timestamp":1732031714000},"page":"e40525","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Research hotspots and trends related to pain in gouty arthritis from 2014 to 2024: A bibliometric analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-5344","authenticated-orcid":false,"given":"Chengyin","family":"Lu","sequence":"first","affiliation":[{"name":"The Second Clinic College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Luo","sequence":"additional","affiliation":[{"name":"The Second Clinic College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Hu","sequence":"additional","affiliation":[{"name":"The Second Clinic College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiong","sequence":"additional","affiliation":[{"name":"The Second Clinic College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China"},{"name":"Department of Orthopedics, The First Hospital of Hunan University Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Hunan Provincial People\u2019s Hospital (The First Hospital of Hunan Normal University), Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The First Hospital of Hunan University Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7037-7151","authenticated-orcid":false,"given":"Gonghui","family":"Jian","sequence":"additional","affiliation":[{"name":"College of Integrative Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"110756","DOI":"10.1016\/j.intimp.2023.110756","article-title":"Autophagy induced by PP121 alleviates MSU crystal-induced acute gouty arthritis via inhibition of the NLRP3 inflammasome.","volume":"123","author":"Yuan","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"117527","DOI":"10.1016\/j.jep.2023.117527","article-title":"Effect and mechanism of aqueous extract of Chinese herbal prescription (TFK) in treating gout arthritis.","volume":"321","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1353615","DOI":"10.3389\/fphar.2024.1353615","article-title":"Gut-immunity-joint axis: a new therapeutic target for gouty arthritis.","volume":"15","author":"Chen","year":"2024","journal-title":"Front Pharmacol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13063-022-06338-1","article-title":"Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial.","volume":"23","author":"Shang","year":"2022","journal-title":"Trials"},{"key":"R5-20250504","first-page":"e38247","article-title":"Dual-energy computed tomography (DECT) resolves the diagnostic dilemma in an atypically presenting case of gout.","volume":"15","author":"Sanghavi","year":"2023","journal-title":"Cureus"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20250504","first-page":"CD010120","article-title":"Non-steroidal anti-inflammatory drugs for acute gout.","volume":"2021","author":"Van Durme","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250504","first-page":"e46649","article-title":"Gout treatment and clinical considerations: the role of pegloticase, colchicine, and febuxostat.","volume":"15","author":"Quintana","year":"2023","journal-title":"Cureus"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/10998004211063547","article-title":"Cold water immersion directly and mediated by alleviated pain to promote quality of life in Indonesian with gout arthritis: a community-based randomized controlled trial.","volume":"24","author":"Kurniasari","year":"2022","journal-title":"Biol Res Nurs"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1021\/acs.jmedchem.3c01710","article-title":"Agents for the treatment of gout: current advances and future perspectives.","volume":"66","author":"Zeng","year":"2023","journal-title":"J Med Chem"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e0261940","DOI":"10.1371\/journal.pone.0261940","article-title":"Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.","volume":"17","author":"Van De Laar","year":"2022","journal-title":"PLoS One"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"106665","DOI":"10.1016\/j.ejps.2023.106665","article-title":"Formulation development of pharmaceutical nanoemulgel for transdermal delivery of feboxostat: physical characterization and in vivo evaluation.","volume":"195","author":"Khan","year":"2024","journal-title":"Eur J Pharm Sci"},{"issue":"Pt A","key":"R13-20250504","doi-asserted-by":"crossref","first-page":"115875","DOI":"10.1016\/j.jep.2022.115875","article-title":"Qingre Huazhuo Jiangsuan Decoction promotes autophagy by inhibiting PI3K\/AKT\/mTOR signaling pathway to relieve acute gouty arthritis.","volume":"302","author":"Liu","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1295154","DOI":"10.3389\/fimmu.2023.1295154","article-title":"Electroacupuncture for acute gouty arthritis: a systematic review and meta-analysis of randomized controlled trials.","volume":"14","author":"Ni","year":"2024","journal-title":"Front Immunol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13020-023-00800-1","article-title":"Electroacupuncture improves gout arthritis pain via attenuating ROS-mediated NLRP3 inflammasome overactivation.","volume":"18","author":"Wei","year":"2023","journal-title":"Chin Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.42335","article-title":"A randomized, placebo-controlled study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase: primary efficacy and safety findings.","volume":"75","author":"Botson","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e37684","DOI":"10.1097\/MD.0000000000037684","article-title":"Research hotspots and trend of wrist arthroscopy: a bibliometrics analysis from 2013 to 2023.","volume":"103","author":"Lu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"Van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis.","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors.","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 gout classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome.","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout.","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout.","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"115957","DOI":"10.1016\/j.biopha.2023.115957","article-title":"Activation of Nrf2 antioxidant signaling alleviates gout arthritis pain and inflammation.","volume":"170","author":"Zeng","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"114175","DOI":"10.1016\/j.biopha.2022.114175","article-title":"Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.","volume":"158","author":"Wu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.2147\/JIR.S434587","article-title":"Mastoparan M suppressed NLRP3 inflammasome activation by inhibiting MAPK\/NF-\u03baB and oxidative stress in gouty arthritis.","volume":"16","author":"Yan","year":"2023","journal-title":"J Inflamm Res"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","article-title":"Role of NLRP3 in the pathogenesis and treatment of gout arthritis.","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acr.24402","article-title":"Efficacy and safety of pharmacologic interventions in patients experiencing a gout flare: a systematic review and network meta-analysis.","volume":"73","author":"Zeng","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jbspin.2020.05.001","article-title":"2020 Recommendations from the French Society of Rheumatology for the management of gout: management of acute flares.","volume":"87","author":"Latourte","year":"2020","journal-title":"Joint Bone Spine"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1136\/annrheumdis-2019-216643","article-title":"Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.","volume":"80","author":"Parperis","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13020-020-00398-8","article-title":"Effects of external application of compound Qingbi granules on acute gouty arthritis with dampness-heat syndrome: a randomized controlled trial.","volume":"15","author":"Ren","year":"2020","journal-title":"Chin Med"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"102241","DOI":"10.1016\/j.coph.2022.102241","article-title":"Emerging strategies for treating gout.","volume":"65","author":"Huddleston","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"R36-20250504","first-page":"3167","article-title":"Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.","volume":"12","author":"Li","year":"2020","journal-title":"Am J Transl Res"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.51866\/cr.65","article-title":"Delayed hypersensitivity reaction to allopurinol: a case report.","volume":"18","author":"Mohammad","year":"2023","journal-title":"Malays Fam Physician"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.ejps.2022.106180","article-title":"Identification of potential biomarkers of gout through competitive endogenous RNA network analysis.","volume":"173","author":"Li","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"798719","DOI":"10.3389\/fimmu.2021.798719","article-title":"Identification of inflammation-related biomarker pro-ADM for male patients with gout by comprehensive analysis.","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2665-9913(21)00319-2","article-title":"Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials.","volume":"4","author":"Stamp","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.","volume":"78","author":"Bursill","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American college of rheumatology guideline for the management of gout.","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/art.40233","article-title":"Effects of febuxostat in early gout: a randomized, double-blind, placebo-controlled study.","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2017-212046","article-title":"Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol.","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-018-1788-4","article-title":"Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.","volume":"21","author":"Dalbeth","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/art.40929","article-title":"Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual-energy computed tomography imaging study within a randomized, controlled trial.","volume":"71","author":"Dalbeth","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.42055","article-title":"Intensive serum urate lowering with oral urate-lowering therapy for erosive gout: a randomized double-blind controlled trial.","volume":"74","author":"Dalbeth","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1038\/s41598-022-17257-1","article-title":"Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation.","volume":"12","author":"Dalbeth","year":"2022","journal-title":"Sci Rep"},{"key":"R49-20250504","first-page":"acr.25283","article-title":"Superiority of low-dose benzbromarone add-on to low-dose febuxostat compared with febuxostat monotherapy in gout with combined-type hyperuricemia.","volume":"5","author":"Xue","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R50-20250504","first-page":"kead574","article-title":"Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares.","volume":"8","author":"Russell","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12906-023-04042-4","article-title":"Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice.","volume":"23","author":"Lin","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1051682","DOI":"10.3389\/fcimb.2022.1051682","article-title":"The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment.","volume":"12","author":"Tong","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:03:01Z","timestamp":1746320581000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":51,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040525","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}